The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | A study investigating the three-dimensional structure and interactions of BcRs in CLL
Massimo Degano, PhD, Fondazione Centro San Raffaele, Milan, Italy, discusses a study investigating the three-dimensional structure of B-cell receptors (BcRs) in chronic lymphocytic leukemia (CLL) cells. His research reveals a unique interaction that BcRs can have with themselves, acting as both the receptor and antigen. However, these interactions differ from patient to patient, highlighting the need for patient-specific studies to develop targeted therapies. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
